Promising Therapeutic Strategies for Patients with Progressive Metastatic Non-Small Cell Lung Cancer

Dr Melissa Johnson from Sarah Cannon Research Institute in Nashville, Tennessee, discusses available data with antibody-drug conjugates with established and investigational targets in patients with non-small cell lung cancer, moderated by Dr Neil Love. Produced by Research To Practice.

CME information and select publications here.